126 related articles for article (PubMed ID: 38423787)
1. Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [
Hardiansyah D; Yousefzadeh-Nowshahr E; Kind F; Beer AJ; Ruf J; Glatting G; Mix M
J Nucl Med; 2024 Apr; 65(4):566-572. PubMed ID: 38423787
[TBL] [Abstract][Full Text] [Related]
2. Population-based model selection for an accurate estimation of time-integrated activity using non-linear mixed-effects modelling.
Hardiansyah D; Riana A; Eiber M; Beer AJ; Glatting G
Z Med Phys; 2023 Feb; ():. PubMed ID: 36813594
[TBL] [Abstract][Full Text] [Related]
3. Single-time-point dosimetry using model selection and nonlinear mixed-effects modelling: a proof of concept.
Hardiansyah D; Riana A; Beer AJ; Glatting G
EJNMMI Phys; 2023 Feb; 10(1):12. PubMed ID: 36759362
[TBL] [Abstract][Full Text] [Related]
4. Toward Single-Time-Point Image-Based Dosimetry of
Brosch-Lenz J; Delker A; Völter F; Unterrainer LM; Kaiser L; Bartenstein P; Ziegler S; Rahmim A; Uribe C; Böning G
J Nucl Med; 2023 May; 64(5):767-774. PubMed ID: 36657980
[TBL] [Abstract][Full Text] [Related]
5. [
Schaefer-Schuler A; Burgard C; Blickle A; Maus S; Petrescu C; Petto S; Bartholomä M; Stemler T; Ezziddin S; Rosar F
Theranostics; 2024; 14(5):1829-1840. PubMed ID: 38505615
[No Abstract] [Full Text] [Related]
6. Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model.
Hardiansyah D; Riana A; Beer AJ; Glatting G
Z Med Phys; 2023 Feb; 33(1):70-81. PubMed ID: 35961809
[TBL] [Abstract][Full Text] [Related]
7. Single-Time-Point Imaging for Dosimetry After [
Wang C; Peterson AB; Wong KK; Roseland ME; Schipper MJ; Dewaraja YK
J Nucl Med; 2023 Sep; 64(9):1463-1470. PubMed ID: 37500260
[TBL] [Abstract][Full Text] [Related]
8. A population-based method to determine the time-integrated activity in molecular radiotherapy.
Hardiansyah D; Riana A; Kletting P; Zaid NRR; Eiber M; Pawiro SA; Beer AJ; Glatting G
EJNMMI Phys; 2021 Dec; 8(1):82. PubMed ID: 34905131
[TBL] [Abstract][Full Text] [Related]
9. Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT images at two imaging time points.
Chen G; Lu Z; Jiang H; Afshar-Oromieh A; Rominger A; Shi K; Mok GSP
Front Med (Lausanne); 2023; 10():1246881. PubMed ID: 38020081
[TBL] [Abstract][Full Text] [Related]
10. A step toward simplified dosimetry of radiopharmaceutical therapy via SPECT frame duration reduction.
Yazdani E; Asadi M; Geramifar P; Karamzade-Ziarati N; Vosoughi H; Kazemi-Jahromi M; Sadeghi M
Appl Radiat Isot; 2024 Aug; 210():111378. PubMed ID: 38820867
[TBL] [Abstract][Full Text] [Related]
11. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for
Peterson AB; Mirando DM; Dewaraja YK
EJNMMI Res; 2023 Jun; 13(1):57. PubMed ID: 37306783
[TBL] [Abstract][Full Text] [Related]
12. Renal and Multiorgan Safety of
Herrmann K; Rahbar K; Eiber M; Sparks R; Baca N; Krause BJ; Lassmann M; Jentzen W; Tang J; Chicco D; Klein P; Blumenstein L; Basque JR; Kurth J
J Nucl Med; 2024 Jan; 65(1):71-78. PubMed ID: 38050121
[TBL] [Abstract][Full Text] [Related]
13. Investigation of image-based lesion and kidney dosimetry protocols for
Resch S; Takayama Fouladgar S; Zacherl M; Sheikh GT; Liubchenko G; Rumiantcev M; Unterrainer LM; Wenter V; Bartenstein P; Ziegler SI; Ilhan H; Beyer L; Böning G; Delker A
EJNMMI Phys; 2023 Feb; 10(1):11. PubMed ID: 36757516
[TBL] [Abstract][Full Text] [Related]
14. An Intrapatient Dosimetry Comparison of
Rinscheid A; Gäble A; Wienand G; Pfob C; Dierks A; Kircher M; Trepel M; Weckermann D; Lapa C; Bundschuh RA
J Nucl Med; 2023 Dec; 64(12):1918-1924. PubMed ID: 37770108
[TBL] [Abstract][Full Text] [Related]
15. Uncertainty Analysis of Time-Integrated Activity Coefficient in Single-Time-Point Dosimetry Using Bayesian Fitting Method.
Jundi AF; Naqiyyun MD; Patrianesha BB; Mu'minah IAS; Riana A; Hardiansyah D
Nucl Med Mol Imaging; 2024 May; 58(3):120-128. PubMed ID: 38633290
[TBL] [Abstract][Full Text] [Related]
16. Influence of sampling schedules on [
Rinscheid A; Kletting P; Eiber M; Beer AJ; Glatting G
EJNMMI Phys; 2020 Jun; 7(1):41. PubMed ID: 32556844
[TBL] [Abstract][Full Text] [Related]
17. Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for [Formula: see text]Lu-DOTATATE therapy.
Vergnaud L; Giraudet AL; Moreau A; Salvadori J; Imperiale A; Baudier T; Badel JN; Sarrut D
EJNMMI Phys; 2022 May; 9(1):37. PubMed ID: 35575946
[TBL] [Abstract][Full Text] [Related]
18. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in clinical patients and realistic simulations.
Peterson AB; Mirando DM; Dewaraja YK
Res Sq; 2023 Apr; ():. PubMed ID: 37131738
[No Abstract] [Full Text] [Related]
19. Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT.
Grob D; Privé BM; Muselaers CHJ; Mehra N; Nagarajah J; Konijnenberg MW; Peters SMB
EJNMMI Phys; 2024 Apr; 11(1):34. PubMed ID: 38568428
[TBL] [Abstract][Full Text] [Related]
20. Prostate-Specific Membrane Antigen Radioligand Therapy Using
Schuchardt C; Zhang J; Kulkarni HR; Chen X; Müller D; Baum RP
J Nucl Med; 2022 Aug; 63(8):1199-1207. PubMed ID: 34887335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
